# OnCo record crossignal-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/crossignal-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "crossignal-therapeutics" ;
  schema:name "Crossignal Therapeutics"@en ;
  schema:description "Crossignal Therapeutics develops small-molecule medicines meant to stop tumours hiding from the immune system. Its lead drug, CT3001, is in an early trial in advanced bowel, pancreatic and other solid cancers."@en ;
  schema:url <https://onco.cc/companies/crossignal-therapeutics/>, <https://crossignaltherapeutics.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://crossignaltherapeutics.com/>, <https://crossignaltherapeutics.com/clinical-trial> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/nsclc/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/>, <https://onco.cc/fronts/targeted-therapy/> ;
  onco:trials <https://onco.cc/trials/nct06598007/> .